Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement.

Liberto JM, Qi S, Rana MM, Shih IM, Wang TL

Open source

DOI
10.64898/2026.09.14.751179
Published
2026 Sep 16
Container
bioRxiv : the preprint server for biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.64898/2026.09.14.751179,
  title = {Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement.},
  author = {Liberto JM and Qi S and Rana MM and Shih IM and Wang TL},
  year = {2026},
  journal = {bioRxiv : the preprint server for biology},
  doi = {10.64898/2026.09.14.751179},
  url = {https://doi.org/10.64898/2026.09.14.751179}
}

RIS

TY  - JOUR
TI  - Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement.
AU  - Liberto JM
AU  - Qi S
AU  - Rana MM
AU  - Shih IM
AU  - Wang TL
PY  - 2026
JO  - bioRxiv : the preprint server for biology
DO  - 10.64898/2026.09.14.751179
UR  - https://doi.org/10.64898/2026.09.14.751179
ER  - 

APA

JM, L., S, Q., MM, R., IM, S., & TL, W. (2026). Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.09.14.751179

Source records